MBS146336 | Recombinant Human Tumor Necrosis Factor Receptor 13B

Recombinant Human Tumor Necrosis Factor Receptor 13B | MBS146336 | MyBiosource

Product Short Name: [Tumor Necrosis Factor Receptor 13B]

Product Name Synonyme: [TACI Human; Tumor Necrosis Factor Receptor 13B Human Recombinant; CD267; CVID; CVID2; TACI; TNFRSF14B; Tumor necrosis factor receptor superfamily; member 13B; Tumor necrosis factor receptor superfamily; member 13B; isoform CRA_a; TNFRSF13B]

Other Names: [tumor necrosis factor receptor superfamily member 13B; TACI; tumor necrosis factor receptor superfamily member 13B; transmembrane activator and CAML interactor; tumor necrosis factor receptor 13B; tumor necrosis factor receptor superfamily, member 13B; TACI]

Product Gene Name: [TACI ]

Product Gene Name Synonyme: N/A

Other Gene Names: [TNFRSF13B; TACI; CVID; RYZN; TACI; CD267; CVID2; IGAD2; TNFRSF14B]

Clonality: N/A

Isotype: N/A

Clone: N/A

Host: E Coli

Reactivity: N/A

Specificity: N/A

Purity: Greater than 95.0% as determined by: (a) Analysis by RP-HPLC. (b) Analysis by SDS-PAGE.

Form: TACI protein was lyophilized from a 0.2 um filtered concentrated solution in PBS, pH 7.4.
Sterile Filtered White lyophilized (freeze-dried) powder.

Concentration: N/A

Storage Stability: Lyophilized TACI although stable at room temperature for 3 weeks, should be stored desiccated below -18 degree C. Upon reconstitution TACI should be stored at 4 degree C between 2-7 days and for future use below -18 degree C. For long term storage it is recommended to add a carrier protein (0.1% HSA or BSA). Please prevent freeze-thaw cycles.

Tested Application: N/A